Product Portfolio

Product Portfolio

Meda’s product portfolio is well diversified and spans several therapeutic and ¬product areas. Rx drugs account for around 60% of net sales, while non-prescription drugs – consisting of Cx and OTC products – account for around 40%. 

Meda's products fall within several therapy areas but the main focus is Respiratory, Dermatology, and Pain and Inflammation. 

For additional information about Meda's products and their availability see each country's local website.

Selected therapy areas and product areas

This website is intended for people seeking information on Meda AB's Global operations.
We also have national marketing sites. Links to these are under Meda Worldwide at the top of the page.